These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 32843121)

  • 1. Antibody evidence of SARS-CoV-2 infection in healthcare workers in the Bronx.
    Sydney ER; Kishore P; Laniado I; Rucker LM; Bajaj K; Zinaman MJ
    Infect Control Hosp Epidemiol; 2020 Nov; 41(11):1348-1349. PubMed ID: 32843121
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevalence of SARS-CoV-2 Antibodies Among Healthcare Workers at a Tertiary Academic Hospital in New York City.
    Mansour M; Leven E; Muellers K; Stone K; Mendu DR; Wajnberg A
    J Gen Intern Med; 2020 Aug; 35(8):2485-2486. PubMed ID: 32495088
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevalence of SARS-CoV-2 Antibodies in Health Care Personnel in the New York City Area.
    Moscola J; Sembajwe G; Jarrett M; Farber B; Chang T; McGinn T; Davidson KW;
    JAMA; 2020 Sep; 324(9):893-895. PubMed ID: 32780804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seroprevalence of SARS-Cov-2 in 646 professionals at the Rothschild Foundation Hospital (ProSeCoV study).
    Mesnil M; Joubel K; Yavchitz A; Miklaszewski N; Devys JM
    Anaesth Crit Care Pain Med; 2020 Oct; 39(5):595-596. PubMed ID: 32861816
    [No Abstract]   [Full Text] [Related]  

  • 5. Seroprevalence of antibodies against SARS-CoV-2 among health care workers in a large Spanish reference hospital.
    Garcia-Basteiro AL; Moncunill G; Tortajada M; Vidal M; Guinovart C; Jiménez A; Santano R; Sanz S; Méndez S; Llupià A; Aguilar R; Alonso S; Barrios D; Carolis C; Cisteró P; Chóliz E; Cruz A; Fochs S; Jairoce C; Hecht J; Lamoglia M; Martínez MJ; Mitchell RA; Ortega N; Pey N; Puyol L; Ribes M; Rosell N; Sotomayor P; Torres S; Williams S; Barroso S; Vilella A; Muñoz J; Trilla A; Varela P; Mayor A; Dobaño C
    Nat Commun; 2020 Jul; 11(1):3500. PubMed ID: 32641730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lower detection rates of SARS-COV2 antibodies in cancer patients versus health care workers after symptomatic COVID-19.
    Solodky ML; Galvez C; Russias B; Detourbet P; N'Guyen-Bonin V; Herr AL; Zrounba P; Blay JY
    Ann Oncol; 2020 Aug; 31(8):1087-1088. PubMed ID: 32360743
    [No Abstract]   [Full Text] [Related]  

  • 7. Serosurvey of SARS-CoV-2 among hospital visitors in China.
    Liang W; Lin Y; Bi J; Li J; Liang Y; Wong SS; Zanin M; Yang Z; Li C; Zhong R; Jiang G; Han G; Hu D; He J; Zhong N
    Cell Res; 2020 Sep; 30(9):817-818. PubMed ID: 32686766
    [No Abstract]   [Full Text] [Related]  

  • 8. Antibody Responses to SARS-CoV-2 at 8 Weeks Postinfection in Asymptomatic Patients.
    Choe PG; Kang CK; Suh HJ; Jung J; Kang E; Lee SY; Song KH; Kim HB; Kim NJ; Park WB; Kim ES; Oh MD
    Emerg Infect Dis; 2020 Oct; 26(10):2484-2487. PubMed ID: 32579877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2-specific antibody detection in healthcare workers in Germany with direct contact to COVID-19 patients.
    Korth J; Wilde B; Dolff S; Anastasiou OE; Krawczyk A; Jahn M; Cordes S; Ross B; Esser S; Lindemann M; Kribben A; Dittmer U; Witzke O; Herrmann A
    J Clin Virol; 2020 Jul; 128():104437. PubMed ID: 32434708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 antibody performances: we need better criteria.
    Galli C; Plebani M
    Clin Chem Lab Med; 2020 Sep; 58(12):e303-e305. PubMed ID: 32970607
    [No Abstract]   [Full Text] [Related]  

  • 11. Seroprevalence of SARS-CoV-2-Specific Antibodies Among Adults in Los Angeles County, California, on April 10-11, 2020.
    Sood N; Simon P; Ebner P; Eichner D; Reynolds J; Bendavid E; Bhattacharya J
    JAMA; 2020 Jun; 323(23):2425-2427. PubMed ID: 32421144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology of SARS-CoV-2 antibodies among firefighters/paramedics of a US fire department: a cross-sectional study.
    Caban-Martinez AJ; Schaefer-Solle N; Santiago K; Louzado-Feliciano P; Brotons A; Gonzalez M; Issenberg SB; Kobetz E
    Occup Environ Med; 2020 Dec; 77(12):857-861. PubMed ID: 32764107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 seroprevalence among parturient women in Philadelphia.
    Flannery DD; Gouma S; Dhudasia MB; Mukhopadhyay S; Pfeifer MR; Woodford EC; Gerber JS; Arevalo CP; Bolton MJ; Weirick ME; Goodwin EC; Anderson EM; Greenplate AR; Kim J; Han N; Pattekar A; Dougherty J; Kuthuru O; Mathew D; Baxter AE; Vella LA; Weaver J; Verma A; Leite R; Morris JS; Rader DJ; Elovitz MA; Wherry EJ; Puopolo KM; Hensley SE
    Sci Immunol; 2020 Jul; 5(49):. PubMed ID: 32727884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of indigenous IgG ELISA for the detection of anti-SARS-CoV-2 IgG.
    Sapkal G; Shete-Aich A; Jain R; Yadav PD; Sarkale P; Lakra R; Baradkar S; Deshpande GR; Mali D; Tilekar BN; Majumdar T; Kaushal H; Gurav Y; Gupta N; Mohandas S; Deshpande K; Kaduskar O; Salve M; Patil S; Gaikwad S; Sugunan AP; Ashok M; Giri S; Shastri J; Abraham P; Gangakhedkar RR;
    Indian J Med Res; 2020 May; 151(5):444-449. PubMed ID: 32611915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of SARS-CoV-2 IgG antibody response in PCR positive patients: Comparison of nine tests in relation to clinical data.
    Naaber P; Hunt K; Pesukova J; Haljasmägi L; Rumm P; Peterson P; Hololejenko J; Eero I; Jõgi P; Toompere K; Sepp E
    PLoS One; 2020; 15(10):e0237548. PubMed ID: 33108380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Promise and Peril of Antibody Testing for COVID-19.
    Abbasi J
    JAMA; 2020 May; 323(19):1881-1883. PubMed ID: 32301958
    [No Abstract]   [Full Text] [Related]  

  • 17. Natural History of Asymptomatic SARS-CoV-2 Infection.
    Sakurai A; Sasaki T; Kato S; Hayashi M; Tsuzuki SI; Ishihara T; Iwata M; Morise Z; Doi Y
    N Engl J Med; 2020 Aug; 383(9):885-886. PubMed ID: 32530584
    [No Abstract]   [Full Text] [Related]  

  • 18. Detection of serum IgM and IgG for COVID-19 diagnosis.
    Zhong L; Chuan J; Gong B; Shuai P; Zhou Y; Zhang Y; Jiang Z; Zhang D; Liu X; Ma S; Huang Y; Lin H; Wang Q; Huang L; Jiang D; Hao F; Tang J; Zheng C; Yu H; Wang Z; Jiang Q; Zeng T; Luo M; Zeng F; Zeng F; Liu J; Tian J; Xu Y; Long T; Xu K; Yang X; Liu Y; Shi Y; Jiang L; Yang Z
    Sci China Life Sci; 2020 May; 63(5):777-780. PubMed ID: 32270436
    [No Abstract]   [Full Text] [Related]  

  • 19. Patterns of IgG and IgM antibody response in COVID-19 patients.
    Liu X; Wang J; Xu X; Liao G; Chen Y; Hu CH
    Emerg Microbes Infect; 2020 Dec; 9(1):1269-1274. PubMed ID: 32515684
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevalence of COVID-19 antibodies in healthcare workers at the peak of the pandemic in Mumbai, India: A preliminary study.
    Singhal T; Shah S; Naik R; Kazi A; Thakkar P
    Indian J Med Microbiol; 2020; 38(3 & 4):461-463. PubMed ID: 33154264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.